NY-ESO-1 antibody as a novel tumour marker of gastric cancer

被引：0
|
作者：
S Fujiwara
H Wada
J Kawada
R Kawabata
T Takahashi
J Fujita
T Hirao
K Shibata
Y Makari
S Iijima
H Nishikawa
A A Jungbluth
Y Nakamura
Y Kurokawa
M Yamasaki
H Miyata
K Nakajima
S Takiguchi
E Nakayama
M Mori
Y Doki
机构：
[1] Graduate School of Medicine,Department of Gastroenterological Surgery
[2] Osaka University,Department of Experimental Immunology
[3] 2-2 Yamadaoka,undefined
[4] Suita-city (E-2),undefined
[5] Osaka 565-0871,undefined
[6] Japan,undefined
[7] Surgery,undefined
[8] Toyonaka Municipal Hospital,undefined
[9] Surgery,undefined
[10] Ikeda City Hospital,undefined
[11] Surgery,undefined
[12] Minoh City Hospital,undefined
[13] Immunology Frontier Research Center,undefined
[14] Osaka University,undefined
[15] 3-1 Yamadaoka,undefined
[16] Suita-city,undefined
[17] Osaka 565-0871,undefined
[18] Japan,undefined
[19] Ludwig Institute for Cancer Research,undefined
[20] New York Branch at Memorial Sloan-Kettering Cancer Center,undefined
[21] Faculty of Health and Welfare,undefined
[22] Kawasaki University of Medical Welfare,undefined
来源：
British Journal of Cancer | 2013年 / 108卷
关键词：
surgical treatment; detection marker; follow-up marker; recurrence; prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1119 / 1125
页数：6
相关论文
共 50 条
  • [1] NY-ESO-1 antibody as a novel tumour marker of gastric cancer
    Fujiwara, S.
    Wada, H.
    Kawada, J.
    Kawabata, R.
    Takahashi, T.
    Fujita, J.
    Hirao, T.
    Shibata, K.
    Makari, Y.
    Iijima, S.
    Nishikawa, H.
    Jungbluth, A. A.
    Nakamura, Y.
    Kurokawa, Y.
    Yamasaki, M.
    Miyata, H.
    Nakajima, K.
    Takiguchi, S.
    Nakayama, E.
    Mori, M.
    Doki, Y.
    BRITISH JOURNAL OF CANCER, 2013, 108 (05) : 1119 - 1125
  • [2] The role of the NY-ESO-1 in the prognosis of gastric cancer
    Misir, Zvonimir
    Glavcic, Goran
    Jankovic, Suzana
    Kruljac, Ivan
    Cugura-Filipovic, Jaksa
    Cimiimic, Kristina
    Ulamec, Monika
    BIOMOLECULES AND BIOMEDICINE, 2024, 24 (04): : 813 - 820
  • [3] Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer
    Saito, Takuro
    Kurkawa, Yukinori
    Fujitani, Kazumasa
    Kawabata, Ryohei
    Takeno, Atsushi
    Mikami, Jota
    Endo, Shunji
    Matsuyama, Jin
    Akamaru, Yusuke
    Hirota, Masashi
    Kishi, Kentaro
    Tanaka, Koji
    Takahashi, Tsuyoshi
    Wada, Hisashi
    Eguchi, Hidetoshi
    Doki, Yuichiro
    CANCER SCIENCE, 2025, 116 : 488 - 488
  • [4] NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus
    Chen, Ji-Li
    Dawoodji, Amina
    Tarlton, Andrea
    Gnjatic, Sacha
    Tajar, Abdelouahid
    Karydis, Ioannis
    Browning, Judy
    Pratap, Sarah
    Verfaille, Christian
    Venhaus, Ralph R.
    Pan, Linda
    Altman, Douglas G.
    Cebon, Jonathan S.
    Old, Lloyd L.
    Nathan, Paul
    Ottensmeier, Christian
    Middleton, Mark
    Cerundolo, Vincenzo
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (06) : E590 - E601
  • [5] Public NY-ESO-1 specific TCRs as novel biomarkers for immune monitoring of NY-ESO-1 positive cancer patients
    Lu, Hailing
    Pollack, Seth
    Somaiah, Neeta
    Chawla, Sant
    Hwu, Patrick
    Vignali, Marissa
    Rytlewski, Julie
    Gnjatic, Sacha
    ter Meulen, Jan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [6] NY-ESO-1 as a predictive and prognostic marker in NSCLC
    John, Tom
    Russell, Prudence
    Barnett, Stephen
    Wainer, Zoe
    White, Shane
    Mitchell, Paul
    Walkiewicz, Marzena
    Boutros, Paul C.
    Starmans, Maud H. W.
    Chen, Yao-Tseng
    Wright, Gavin
    Knight, Simon
    Cebon, Jonathan S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Characterization of NY-ESO-1 gene expression in gastric cancer (GC).
    Lenz, Annika
    Zeng, Jia
    Xiu, Joanne
    Algaze, Sandra
    Jayachandran, Priya
    Soni, Shivani
    Lo, Jae Ho
    Arai, Hiroyuki
    Zhang, Wu
    Brodskiy, Pavel
    Gulhati, Pat
    Weinberg, Benjamin Adam
    Lou, Emil
    Shields, Anthony Frank
    Goldberg, Richard M.
    Marshall, John
    Korn, Wolfgang Michael
    Lenz, Heinz-Josef
    Torres, Evanthia T. Roussos
    Battaglin, Francesca
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [8] Antibody response against NY-ESO-1 in CHP-NY-ESO-1 vaccinated patients
    Kawabata, Ryohei
    Wada, Hisashi
    Isobe, Midori
    Saika, Takashi
    Sato, Shuichiro
    Uenaka, Akiko
    Miyata, Hiroshi
    Yasud, Takushi
    Doki, Yuichiro
    Noguchi, Yuji
    Kumon, Hiromi
    Tsuji, Kazuhide
    Iwatsuki, Keiji
    Shiku, Hiroshi
    Ritter, Gerd
    Murphy, Roger
    Hoffman, Eric
    Old, Lloyd J.
    Monden, Morito
    Nakayama, Eiichi
    INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (10) : 2178 - 2184
  • [9] NY-ESO-1 as a diagnostic and prognostic marker for myxoid liposarcoma
    Jo, Uiree
    Roh, Jin
    Song, Min Jeong
    Cho, Kyung-Ja
    Kim, Wanlim
    Song, Joon Seon
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (02): : 1268 - 1278
  • [10] Evaluation of persisting NY-ESO-1 immunity in patients who have previously been vaccinated with NY-ESO-1 ISCOMATIRX® or NY-ESO-1 protein alone
    Nicholaou, T
    Chen, W
    Davis, ID
    Jackson, H
    Dimopoulos, N
    Barrow, C
    Hopkins, W
    Maraskovsky, E
    Hoffman, E
    Old, LJ
    Cebon, J
    TISSUE ANTIGENS, 2005, 66 (05): : 503 - 503
12345